Logo image of FBRX

FORTE BIOSCIENCES INC (FBRX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:FBRX - US34962G2084 - Common Stock

33.99 USD
+1.5 (+4.62%)
Last: 1/14/2026, 1:51:25 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
FBRX revenue by date.FBRX revenue by date.
40K
-20.00%
18.04M
45,000.00%
40K
-99.78%

-100.00%
14.6M44.119M
202.18%
99.183M
124.81%
211.48M
113.22%
519.52M
145.66%
832.15M
60.18%
EBITDA
YoY % growth
FBRX ebitda by date.FBRX ebitda by date.
-37.34M
-18.80%
-45.22M
-21.10%
-60.67M
-34.17%
N/A
23.80%
N/A
53.60%
N/A
35.20%
N/A
-130.15%
N/A
-15.54%
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
FBRX ebit by date.FBRX ebit by date.
-37.63M
-18.74%
-45.85M
-21.84%
-61.51M
-34.15%
-48.004M
24.76%
N/A
53.57%
N/A
35.32%
-38.658M
-130.22%
-38.966M
-15.63%
-66.636M
-80.10%
-86.166M
-29.31%
-119.447M
-38.63%
-147.968M
-23.88%
-246.07M
-66.30%
-262.984M
-6.87%
-235.722M
10.37%
-48.297M
79.51%
101.24M
309.62%
Operating Margin
FBRX operating margin by date.FBRX operating margin by date.
-94,075.00%-254.16%-153,775.00%N/AN/AN/AN/AN/AN/AN/AN/A-1,013.48%-557.74%-265.15%-111.46%-9.30%12.17%
EPS
YoY % growth
FBRX eps by date.FBRX eps by date.
-2,145.00N/A
62.33%
-1,027.50
-27.17%
-218.79
59.15%
-39.27
90.83%
-0.89
97.70%
-14.79
-1,566.67%
-16.45
-19.95%
-4.38
75.30%
-3.99
9.02%
-4.41
-10.75%
-3.67
16.81%
-5.64
-53.70%
-5.98
-5.96%
-6.13
-2.42%
-1.82
70.27%
1.44
179.27%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.24
49.49%
-1.00
27.04%
-0.85
11.81%
-0.87
12.42%
-0.94
24.18%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-17.239M
-134.51%
-15.198M
5.74%
-15.81M
-36.54%
-16.524M
10.11%
-18.156M
-5.32%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.99
78.19%
-1.090.109.08%
Q2 2025
Q2Q % growth
-0.96
85.78%
-1.130.1715.02%
Q1 2025
Q2Q % growth
-1.37
65.75%
-0.97-0.40-41.38%
Q4 2024
Q2Q % growth
-2.45
47.31%
-3.340.8926.55%
Q3 2024
Q2Q % growth
-4.54
-1,646.15%
-7.272.7337.53%
Q2 2024
Q2Q % growth
-6.75
-1,507.14%
-4.25-2.50-58.82%
Q1 2024
Q2Q % growth
-4.00 -4.210.214.93%
Q4 2023
Q2Q % growth
-4.65
-2,749.11%
-7.142.4934.88%
Q3 2023
Q2Q % growth
-0.26
94.22%
%
Q2 2023
Q2Q % growth
-0.42
-100.00%
%
Q4 2022
Q2Q % growth

96.89%
-0.16%
Q3 2022
Q2Q % growth
-4.50
66.67%
-3.83-0.67-17.65%
Q2 2022
Q2Q % growth
-0.21
98.05%
-0.19-0.02-8.36%
Q1 2022
Q2Q % growth

97.73%
-0.20%
Q4 2021
Q2Q % growth
-5.25
43.24%
-8.162.9135.66%
Q3 2021
Q2Q % growth
-13.50
-20.00%
-9.31-4.19-45.04%
Q2 2021
Q2Q % growth
-10.75
95.48%
-11.030.282.53%
Q1 2021
Q2Q % growth
-9.00
94.42%
-13.394.3932.77%
Q4 2020
Q2Q % growth
-9.25 -14.625.3736.73%
Q3 2020
Q2Q % growth
-11.25 -13.772.5218.30%
Q2 2020
Q2Q % growth
-238.00 -4.85-233.16-4,812.28%
Q1 2020
Q2Q % growth
-161.25 -168.307.054.19%
FBRX Yearly EPS VS EstimatesFBRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -500 -1K -1.5K -2K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
FBRX Yearly Revenue VS EstimatesFBRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -14.47% 4.06% 3.1%
RevenueN/A N/A N/A N/A